Update on parathyroid hormone: New tests and new challenges for external quality assessment

Clinical Biochemistry

Volumn 40, Issue 9-10, 2007, Pages 585-590

  Cole, David E C ^a,b,c,d   Webb, Sharon ^c   Chan, Pak Cheung ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c Ontario Medical Association   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Calcium homeostasis; Parathyroid hormone (PTH); Utilization

Indexed keywords

PARATHYROID HORMONE; PEPTIDE HORMONE;

CALCIUM HOMEOSTASIS; CARBOXY TERMINAL SEQUENCE; CHRONIC KIDNEY DISEASE; HEALTH SURVEY; HORMONE DETERMINATION; HORMONE METABOLISM; HUMAN; IMMUNOASSAY; PARATHYROID DISEASE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TERTIARY HEALTH CARE;

CHEMILUMINESCENT MEASUREMENTS; HUMANS; IMMUNOASSAY; INTRAOPERATIVE CARE; ONTARIO; PARATHYROID HORMONE; PARATHYROIDECTOMY; POSTOPERATIVE CARE; QUALITY CONTROL;

EID: 34249711484     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.03.019     Document Type: Review

References (39)

1. Berson S.A., Yalow R.S., Aurbach G.D., and Potts J.T. Immunoassay of bovine and human parathyroid hormone. Proc. Natl. Acad. Sci. U. S. A. 49 (1963) 613-617
2. Potts J.T. Parathyroid hormone: past and present. J. Endocrinol. 187 (2005) 311-325
3. Murray T.M., Rao L.G., Divieti P., and Bringhurst F.R. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxy-terminal region and related biological actions of carboxyl-terminal ligands. Endocr. Rev. 26 (2005) 78-113
4. Rosenblatt M., Segre G.V., Tregear G.W., Shepard G.L., Tyler G.A., and Potts Jr. J.T. Human parathyroid hormone: synthesis and chemical, biological and immunological evaluation of the carboxyl-terminal region. Endocrinology 103 (1978) 978-984
5. Abou-Samra A.B., Juppner H., Force T., et al. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium. Proc. Natl. Acad Sci. U. S. A. 89 (1992) 2732-2736
6. Slatopolsky E., Finch J., Clay P., et al. A novel mechanism for skeletal resistance in uremia. Kidney Int. 58 (2000) 753-761
7. Thompson M.D., Burnham W.M., and Cole D.E.C. The G-protein coupled receptors: pharmacogenetics and disease. Crit. Rev. Clin. Lab. Sci. 42 (2005) 311-389
8. Hashizume Y., Waguri S., Watanabe T., Kominami E., and Uchiyama Y. Cysteine proteinases in rat parathyroid cells with special reference to their correlation with parathyroid (PTH) in storage granules. J. Histochem. Cytochem. 41 (1993) 273-282
9. Bieglmayer C., Kaczirek K., Prager G., and Niederle B. Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidism: pilot study of the impact of renal function and assay specificity. Clin. Chem. 52 (2006) 1112-1119
10. MacGregor R.R., Jilka R.L., and Hamilton J.W. Formation and secretion of fragments of parathyroid hormone. Identification of cleavage sites. J. Biol. Chem. 261 (1986) 1929-1934
11. D'Amour P., and Brossard J.H. Carboxyl-terminal parathyroid hormone fragments: role in parathyroid hormone physiopathology. Curr. Opin. Nephrol. Hypertens. 14 (2005) 330-336
12. Friedman P.A., and Goodman W.G. PTH(1-84)/PTH(7-84): a balance of power. Am. J. Physiol.: Renal Physiol. 290 (2006) F975-F984
13. Juppner H., and Potts Jr. J.T. Immunoassays for the detection of parathyroid hormone. J. Bone Miner. Res. 17 Suppl. 2 (2002) N81-N86
14. Lepage R., Roy L., Brossard J.H., et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin. Chem. 44 (1998) 805-809
15. Goodman W.G. The evolution of assays for parathyroid hormone. Semin. Dial. 18 (2005) 296-301
16. Chang J.M., Lin S.P., Kuo H.T., et al. 7-84 Parathyroid hormone fragments are proportionally increased with the severity of uremic hyperparathyroidism. Clin. Nephrol. 63 (2005) 351-355
17. Gao P., Scheibel S., Amour D.'P., John M.R., Rao S.D., Schmidt-Gayk H., and Cantor T.L. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J. Bone Miner. Res. 16 4 (2001) 605-614
18. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis. 42 4 Suppl. 3 (2003) S1-S201
19. Ljungdahl N., Haarhaus M., Linder C., and Magnusson P. Comparison of 3 third-generation assays for bio-intact parathyroid hormone. Clin. Chem. 52 (2006) 903-904
20. Souberbielle J.C., Boutten A., Carlier M.C., Chevenne D., Coumaros G., Lawson-Body E., et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int. 70 (2006) 345-350
21. Cantor T., Yang Z., Caraiani N., and Ilamathi E. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions. Clin. Chem. 52 (2006) 1771-1776
22. Torres P.U. The need for reliable serum parathyroid hormone measurements. Kidney Int. 70 (2006) 240-243
23. Goltzman D., and Cole D.E.C. Chap. 36 "Hypoparathyroidism". In: Favus M.J., et al. (Ed). Primer on the Metabolic bone diseases and disorders of mineral metabolism. 6th ed. (2006), American Society for Bone and Mineral Research, D.C. Washington 216-221
24. Lafferty F.W., Hamlin C.R., Corrado K.R., Arnold A., and Shuck J.M. Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves. J. Clin. Endocrinol. Metab. 91 (2006) 3826-3829
25. Boudou P., Ibrahim F., Cormier C., Sarfati E., and Souberbielle J.C. Unexpected serum parathyroid hormone profiles in some patients with primary hyperparathyroidism. Clin. Chem. 52 (2006) 757-760
26. Sturgeon C.M., Ellis A.R., and Al-Sadie. UK NEQAS Annual Review 2005 (Edinburgh) (2005), NEQAS, UK
27. Ollila D.W., Caudle A.S., Cance W.G., Kim H.J., Cusack J.C., Swaesey J.E., and Calvo B.F. Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays. Am. J. Surg. 191 (2006) 52-56
28. Carneiro-Pla D.M., Solorzano C.C., and Irvin III G.L. Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J. Am. Coll. Surg. 202 (2006) 715-722
29. Hortin G.L., and Carter A.B. Intraoperative parathyroid hormone testing: survey of testing program characteristics. Arch. Pathol. Lab. Med. 126 (2002) 1045
30. Kaczirek K., Riss P., Wunderer G., et al. Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism. Surgery 137 (2005) 431
31. Mozzon M., Mortier P.E., Jacob P.M., Soudan B., Boersma A.A., and Proye C.A.G. Surgical management of primary hyperparathyroidism: the case for giving up quick intraoperative PTH assay in favor of routine PTH measurement the morning after. Ann. Surg. 240 (2004) 949-954
32. Lam A., and Kerr P.D. Parathyroid hormone: an early predictor of post-thyroidectomy hypocalcemia. Laryngoscope 113 (2003) 2196
33. McLeod I.K., Arciero C., Noordzij J.P., Stojadinovic A., Peoples G., Melder P.C., et al. The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. Thyroid 16 (2006) 259-265
34. Mahon M.J., Donowitz M., Yun C.C., and Segre G.V. Na+/H+ exchange regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 417 (2002) 858-861
35. Evidence Based Practice for POCT-Intraoperative PTH; NACB; Laboratory Medicine Practice Guidelines; Final Review (Draft)-04/06. http://www.nacb.org/lmpg/poct/POCT_LMPG_final_rev41706.doc.
36. Usdin T.B., Bonner T.I., and Hoare S.R. The parathyroid hormone 2 (PTH2) receptor. Recept. Channels 8 3-4 (2002) 211-218
37. D'Amour P., Brossard J.H., Rousseau L., Nguyen-Yamamoto L., Nassif E., Lazure C., et al. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney Int. 68 3 (2005) 998-1007
38. Gil-Cardenas A., Gamino R., Reza A., Pantoja J.P., and Herrera M.F. Is intraoperative parathyroid hormone assay mandatory for the success of targeted parathyroidectomy?. J. Am. Coll. Surg. 204 (2007) 286-290
39. Asymptomatic primary hyperparathyroidism: standards and guidelines for diagnosis and management in Canada: Consensus Development Task Force on Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism position paper. Endocr Pract 2003;9:400-5.